September 06, 2025

Get In Touch

Bariatric Surgery Reduces Cancer Risk In Adults With NAFLD And Obesity: Study

According to recent research, it has been observed by the investigators at the Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey that bariatric surgery was associated with significant reductions in the risks of any cancer and obesity-related cancer in Nonalcoholic Fatty Liver Disease (NAFLD) patients with severe obesity.
The study is published in the Journal of Gastroenterology.
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and increased risk of cancer. The impacts of bariatric surgery on cancer risk in NAFLD patients are unknown.
Therefore, Vinod K. Rustgi and colleagues conducted the present study to investigate the effect of bariatric surgery on cancer risk in patients with NAFLD and severe obesity using the Marketscan database.
The authors conducted a retrospective cohort study of 18 to 64 years old newly diagnosed NAFLD patients with severe obesity. Cox proportional hazard models were used to examine the association between bariatric surgery, modeled as a time-varying covariate, and the risks of any cancer and obesity-related cancer, while accounting for confounding using inverse probability of treatment weighting (IPTW).
A total of the 98,090 patients were included in the study, 33,435 (34.1%) received bariatric surgery. In those without surgery,1,898 incident cases of cancer occurred over 115,890.11 person-years of follow-up, compared with 925 cancer cases over 67,389.82 person-years among surgery patients (crude rate ratio 0.84; 95% CI: 0.77 to 0.91)
The results showed that-
a. The IPTW-adjusted risk of any cancer and obesity-related cancer was reduced by 18% (hazard ratio [HR] 0.82; 95% CI, 0.76-0.89) and 25% (HR 0.65; 95% CI 0.56-0.75), respectively, in patients with versus without bariatric surgery.
b. The adjusted risks of any cancer and obesity-related cancer were significantly lower in cirrhotic versus non-cirrhotic patients who underwent surgery.
c. In cancer-specific models, bariatric surgery was associated with significant risk reductions for colorectal, pancreatic, endometrial, thyroid cancers, hepatocellular carcinoma, and multiple myeloma.
Hence, it was further concluded that "Bariatric surgery was associated with significant reductions in the risks of any cancer and obesity-related cancer in NAFLD patients with severe obesity."

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!